Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · IEX Real-Time Price · USD
-0.030 (-0.78%)
Jul 16, 2024, 12:24 PM EDT - Market open

Relmada Therapeutics Market Cap

Relmada Therapeutics has a market cap or net worth of $116.95 million as of July 16, 2024. Its market cap has increased by 56.14% in one year.

Market Cap
Enterprise Value
1-Year Change
Stock Price

Market Cap Chart

Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $116.95M, an increase of 106.63%. That is a compound annual growth rate of 8.60%.


DateMarket Cap% Change
Jul 15, 2024115.90M-6.98%
Dec 29, 2023124.60M18.67%
Dec 30, 2022105.00M-73.42%
Dec 31, 2021395.00M-24.17%
Dec 31, 2020520.90M30.00%
Dec 31, 2019400.70M1,125.38%
Dec 31, 201832.70M247.87%
Dec 29, 20179.40M-28.24%
Dec 30, 201613.10M-54.67%
Dec 31, 201528.90M-48.94%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Seer, Inc. 118.83M
Tevogen Bio Holdings 118.63M
Coya Therapeutics 117.20M
Journey Medical 116.48M
TELA Bio 115.88M
Akoya Biosciences 115.07M
BrainsWay 115.01M
KORU Medical Systems 114.41M
Market Cap Rankings